Wendy N. Erber

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

E. Joanna Baxter, Linda M. Scott, Peter J. Campbell et al. · The Lancet · 2005 · 3.4K citations

Hematological Malignancy, Acquired Mutation, Receptor Tyrosine Kinase +9

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

J L Cordell, Brunangelo Falini, Wendy N. Erber et al. · Journal of Histochemistry & Cytochemistry · 1984 · 3.2K citations

Immunocytochemical Technique, Immunology, Alkaline Phosphatase +24

<i>JAK2</i> Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis

Linda M. Scott, Wei Tong, Ross L. Levine et al. · New England Journal of Medicine · 2007 · 1.2K citations · Full text

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

Peter J. Campbell, Linda M. Scott, Georgina Buck et al. · The Lancet · 2005 · 643 citations

Thrombopoiesis, Immunohematology, Thrombosis +10

Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease

Keren Carss, Gavin Arno, Marie Erwood et al. · The American Journal of Human Genetics · 2016 · 463 citations · Full text

Whole-genome Sequencing, Allelic Variant, Genetic Disorder +11